SALE
市場調查報告書

生物製造業的全球市場:2025年前的各產品類型,各來源 、方法,設備,各類型,各技術,各用途,各終端用戶,各地區的 競爭,預測,機會

Global Bio-Manufacturing Market By Product Type, By Source, By Method (Cell Culture, By Equipment, By Type, By Technology, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934742
出版日期 內容資訊 英文 114 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

生物製造業的全球市場:2025年前的各產品類型,各來源 、方法,設備,各類型,各技術,各用途,各終端用戶,各地區的 競爭,預測,機會 Global Bio-Manufacturing Market By Product Type, By Source, By Method (Cell Culture, By Equipment, By Type, By Technology, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球生物製造業市場調查,提供各地區市場展望,市場力學,主要的趨勢,專利分析,競爭情形等資訊,並提供策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 全球生物製造業市場上COVID-19的影響

第4章 摘要整理

第5章 顧客的迴響

第6章 全球生物製造業市場展望

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型 (抗體(MoAb),細胞激素,酵素,融合蛋白品質,荷爾蒙,重組蛋白質,其他)
    • 各來源(微生物培養,植物為主,動物為主)
    • 各方法(細胞培養(哺乳類對微生物),血漿分餾,管柱層析法,均質化,其他)
    • 各設備(塑膠對鋼)
    • 各類型(可重複使用,拋棄式,自動,手動)
    • 各技術(下游處理,上游產業處理,整合,拋棄式)
    • 各用途(診斷對治療)
    • 各終端用戶(生物科技及生物製藥公司,CMO,CRO,CDMO,其他)
    • 各公司(2019)
    • 各地區
  • 產品市場地圖

第7章 亞太地區的生物製造業市場展望

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型
    • 各來源
    • 各方法
    • 各設備
    • 各類型
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 亞太地區:國家分析
    • 中國的生物製造業市場展望
    • 印度的生物製造業市場預測
    • 澳洲的生物製造業市場展望
    • 日本的生物製造業市場展望
    • 韓國的生物製造業市場展望

第8章 歐洲的生物製造業市場展望

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型
    • 各來源
    • 各方法
    • 各設備
    • 各類型
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 歐洲:國家分析
    • 法國的生物製造業市場展望
    • 德國的生物製造業市場展望
    • 英國的生物製造業市場展望
    • 義大利的生物製造業市場展望
    • 西班牙的生物製造業市場展望

第9章 北美的生物製造業市場展望

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型
    • 各來源
    • 各方法
    • 各設備
    • 各類型
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 北美:國家分析
    • 美國的生物製造業市場展望
    • 墨西哥的生物製造業市場展望
    • 加拿大的生物製造業市場預測

第10章 南美的生物製造業市場展望

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型
    • 各來源
    • 各方法
    • 各設備
    • 各類型
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 南美:國家分析
    • 巴西的生物製造業市場展望
    • 阿根廷的生物製造業市場展望
    • 哥倫比亞的生物製造業市場展望

第11章 中東和非洲的生物製造業市場預測

  • 市場規模與預測
    • 價值
  • 市場佔有率與預測
    • 產品類型
    • 各來源
    • 各方法
    • 各設備
    • 各類型
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 中東·非洲地區:國家分析
    • 南非的生物製造業市場展望
    • 沙烏地阿拉伯的生物製造業市場預測
    • UAE生物製造業市場展望
    • 科威特的生物製造業市場展望

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢

  • 細胞株工程
  • 拋棄式製造技術
  • 灌流培養
  • In Silico建模
  • 模塊化工廠

第14章 專利分析

第15章 競爭情形

  • 競爭的展望
  • 企業簡介
  • 公司詳細內容
  • 財務
  • 支援/ 價值鏈分析
  • SWOT分析
  • 主要市場焦點和存在感
  • 計劃投資
  • 市場上的定位
  • 進出口分析(各地區)
  • 價格分析(各國)
  • 主要業者的簡介
    • Abbott Laboratories
    • Abzena Ltd.
    • AGC Biologics GmbH
    • Althea Inc.
    • Amgen Inc.
    • Asymchem Laboratories Inc.
    • Baxter Biopharma Solutions LLC
    • Biocon Ltd.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • Celgene Corporation
    • Danaher Corporation
    • Fujifilm Diosynth Biotechnologies
    • Gilead Sciences, Inc
    • Lonza Group
    • MicroProtein Technologies, Inc.
    • Novo Nordisk
    • Patheon N.V. (Thermo Fischer Scientific)
    • Proteogenix Inc.
    • Proteus Digital Health Inc.

第16章 策略性建議

目錄
Product Code: 4672

Global bio-manufacturing market is expected to grow at a robust pace over the next five years, driven by the rising prevalence of various chronic diseases such as diabetes, cancer, among others. This has been significantly augmenting the demand for effective and faster treatment of these diseases, which in turn is expected to positively influence the bio-manufacturing market. Additionally, increase in the approvals of biologics is further expected to propel the market during forecast period. Furthermore, increasing expenditure by various governments and major market players and adoption of advanced biomanufacturing strategies to increase the development pipeline of drugs, vaccines, enzymes, among others is expected to foster the market growth through 2025. However, the associated risk of product contamination can hamper the market growth. Also, strict regulatory framework regarding GMP can impede the market growth over next few years.

The global bio-manufacturing market is segmented based on product type, source, method, equipment, type, technology, application, end user, and region. Based on product type, the market can be fragmented into antibodies (MoAb), cytokines, enzymes, fusion proteins, hormones, recombinant proteins and others. The monoclonal antibodies segment is expected to dominate the market over the next five years. Additionally, various monoclonal antibodies such as Humira, Remicade, Enbrel, Rituxan, Avastin and Herceptin are available in the market since 2015 which were manufactured using bio-manufacturing process and are doing very well in the market. Also, various monoclonal antibodies are in BLA or equivalent stages thereby driving the growth of segment. Based on technology, the market can be categorized into downstream processing, upstream processing, integrated and single use. The single use segment is expected to witness significant growth on account of the associated benefits such as reduced risk of contamination, higher flexibility in multiproduct facilities, cost-effectiveness, among others. Based on end user, the market can be segmented into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs and others. The CMOs are expected to dominate the market through 2025 due to anticipated increase in demand for clinical and commercial supply of biologics.

Among all the regions, Asia Pacific is expected to witness significant growth in its bio-manufacturing market owing to the increasing healthcare expenditure by the government and various public-private players, especially in countries like China and India. This has allowed a lot of domestic pharmaceutical companies in these countries to develop a range of biologic products such as monoclonal antibodies, recombinant proteins, among others. Additionally, most of the major players operating in the market are expanding in Asia Pacific due to availability of low cost labor as well as manufacturing facilities, thereby creating lucrative opportunities.

Major players operating in the global bio-manufacturing market include Abbott Laboratories, Abzena Ltd., AGC Biologics GmbH, Althea Inc., Amgen Inc., Asymchem Laboratories Inc., Baxter Biopharma Solutions LLC, Biocon Ltd., Biogen Inc., Boehringer Ingelheim GmbH, Celgene Corporation, Danaher Corporation, Fujifilm Diosynth Biotechnologies, Gilead Sciences, Inc, Lonza Group, MicroProtein Technologies, Inc., Novo Nordisk, Patheon N.V. (Thermo Fischer Scientific), Proteogenix Inc., Proteus Digital Health Inc., among others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global bio-manufacturing market from 2015 to 2018.
  • To estimate and forecast the market size of global bio-manufacturing market from 2019 to 2025.
  • To classify and forecast global bio-manufacturing market based on product type, source, method, equipment, type, technology, application, end user, and regional distribution.
  • To identify dominant region or segment in the global bio-manufacturing market.
  • To identify drivers and challenges for global bio-manufacturing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global bio-manufacturing market.
  • To identify and analyze the profile of leading players operating in global bio-manufacturing market.
  • To identify key sustainable strategies adopted by market players in global bio-manufacturing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global bio-manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Bio-manufacturing companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to bio-manufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global bio-manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • By Product Type:

Antibodies (MoAb)

Cytokines

Enzymes

Fusion Proteins

Hormones

Recombinant Proteins

Others

  • By Source:

Microbial Culture

Plant-Based

Animal-Based

  • By Method:

Cell Culture

  • Mammalian
  • Microbial

Blood Plasma Fractionation

Column Chromatography

Homogenization

Others

  • By Equipment:

Plastic

Steel

  • By Type:

Reusable

Disposable

Automated

Manual

  • By Technology:

Downstream Processing

Upstream Processing

Integrated

Single Use

  • By Application:

Diagnostics

Therapeutics

  • By End User:

Biotechnology & Biopharmaceutical Companies

CMOs

CROs

CDMOs

Others

  • By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global bio-manufacturing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bio-Manufacturing Market

4. Executive Summary

5. Voice of Customer

6. Global Bio-Manufacturing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
    • 6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
    • 6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
    • 6.2.4. By Equipment (Plastic v/s Steel)
    • 6.2.5. By Type (Reusable, Disposable, Automated, Manual)
    • 6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
    • 6.2.7. By Application (Diagnostics v/s Therapeutics)
    • 6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
    • 6.2.9. By Company (2019)
    • 6.2.10. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Bio-Manufacturing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Source
    • 7.2.3. By Method
    • 7.2.4. By Equipment
    • 7.2.5. By Type
    • 7.2.6. By Technology
    • 7.2.7. By Application
    • 7.2.8. By End User
    • 7.2.9. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Bio-Manufacturing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By Equipment
        • 7.3.1.2.5. By Type
        • 7.3.1.2.6. By Technology
        • 7.3.1.2.7. By Application
        • 7.3.1.2.8. By End User
    • 7.3.2. India Bio-Manufacturing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By Equipment
        • 7.3.2.2.5. By Type
        • 7.3.2.2.6. By Technology
        • 7.3.2.2.7. By Application
        • 7.3.2.2.8. By End User
    • 7.3.3. Australia Bio-Manufacturing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By Equipment
        • 7.3.3.2.5. By Type
        • 7.3.3.2.6. By Technology
        • 7.3.3.2.7. By Application
        • 7.3.3.2.8. By End User
    • 7.3.4. Japan Bio-Manufacturing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Source
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By Equipment
        • 7.3.4.2.5. By Type
        • 7.3.4.2.6. By Technology
        • 7.3.4.2.7. By Application
        • 7.3.4.2.8. By End User
    • 7.3.5. South Korea Bio-Manufacturing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Source
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By Equipment
        • 7.3.5.2.5. By Type
        • 7.3.5.2.6. By Technology
        • 7.3.5.2.7. By Application
        • 7.3.5.2.8. By End User

8. Europe Bio-Manufacturing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Source
    • 8.2.3. By Method
    • 8.2.4. By Equipment
    • 8.2.5. By Type
    • 8.2.6. By Technology
    • 8.2.7. By Application
    • 8.2.8. By End User
    • 8.2.9. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Bio-Manufacturing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By Equipment
        • 8.3.1.2.5. By Type
        • 8.3.1.2.6. By Technology
        • 8.3.1.2.7. By Application
        • 8.3.1.2.8. By End User
    • 8.3.2. Germany Bio-Manufacturing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By Equipment
        • 8.3.2.2.5. By Type
        • 8.3.2.2.6. By Technology
        • 8.3.2.2.7. By Application
        • 8.3.2.2.8. By End User
    • 8.3.3. United Kingdom Bio-Manufacturing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By Equipment
        • 8.3.3.2.5. By Type
        • 8.3.3.2.6. By Technology
        • 8.3.3.2.7. By Application
        • 8.3.3.2.8. By End User
    • 8.3.4. Italy Bio-Manufacturing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By Equipment
        • 8.3.4.2.5. By Type
        • 8.3.4.2.6. By Technology
        • 8.3.4.2.7. By Application
        • 8.3.4.2.8. By End User
    • 8.3.5. Spain Bio-Manufacturing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By Equipment
        • 8.3.5.2.5. By Type
        • 8.3.5.2.6. By Technology
        • 8.3.5.2.7. By Application
        • 8.3.5.2.8. By End User

9. North America Bio-Manufacturing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Source
    • 9.2.3. By Method
    • 9.2.4. By Equipment
    • 9.2.5. By Type
    • 9.2.6. By Technology
    • 9.2.7. By Application
    • 9.2.8. By End User
    • 9.2.9. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Bio-Manufacturing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By Equipment
        • 9.3.1.2.5. By Type
        • 9.3.1.2.6. By Technology
        • 9.3.1.2.7. By Application
        • 9.3.1.2.8. By End User
    • 9.3.2. Mexico Bio-Manufacturing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By Equipment
        • 9.3.2.2.5. By Type
        • 9.3.2.2.6. By Technology
        • 9.3.2.2.7. By Application
        • 9.3.2.2.8. By End User
    • 9.3.3. Canada Bio-Manufacturing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By Equipment
        • 9.3.3.2.5. By Type
        • 9.3.3.2.6. By Technology
        • 9.3.3.2.7. By Application
        • 9.3.3.2.8. By End User

10. South America Bio-Manufacturing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Source
    • 10.2.3. By Method
    • 10.2.4. By Equipment
    • 10.2.5. By Type
    • 10.2.6. By Technology
    • 10.2.7. By Application
    • 10.2.8. By End User
    • 10.2.9. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-Manufacturing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By Equipment
        • 10.3.1.2.5. By Type
        • 10.3.1.2.6. By Technology
        • 10.3.1.2.7. By Application
        • 10.3.1.2.8. By End User
    • 10.3.2. Argentina Bio-Manufacturing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By Equipment
        • 10.3.2.2.5. By Type
        • 10.3.2.2.6. By Technology
        • 10.3.2.2.7. By Application
        • 10.3.2.2.8. By End User
    • 10.3.3. Colombia Bio-Manufacturing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By Equipment
        • 10.3.3.2.5. By Type
        • 10.3.3.2.6. By Technology
        • 10.3.3.2.7. By Application
        • 10.3.3.2.8. By End User

11. Middle East and Africa Bio-Manufacturing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Source
    • 11.2.3. By Method
    • 11.2.4. By Equipment
    • 11.2.5. By Type
    • 11.2.6. By Technology
    • 11.2.7. By Application
    • 11.2.8. By End User
    • 11.2.9. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Bio-Manufacturing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Method
        • 11.3.1.2.4. By Equipment
        • 11.3.1.2.5. By Type
        • 11.3.1.2.6. By Technology
        • 11.3.1.2.7. By Application
        • 11.3.1.2.8. By End User
    • 11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Method
        • 11.3.2.2.4. By Equipment
        • 11.3.2.2.5. By Type
        • 11.3.2.2.6. By Technology
        • 11.3.2.2.7. By Application
        • 11.3.2.2.8. By End User
    • 11.3.3. UAE Bio-Manufacturing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Method
        • 11.3.3.2.4. By Equipment
        • 11.3.3.2.5. By Type
        • 11.3.3.2.6. By Technology
        • 11.3.3.2.7. By Application
        • 11.3.3.2.8. By End User
    • 11.3.4. Kuwait Bio-Manufacturing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product Type
        • 11.3.4.2.2. By Source
        • 11.3.4.2.3. By Method
        • 11.3.4.2.4. By Equipment
        • 11.3.4.2.5. By Type
        • 11.3.4.2.6. By Technology
        • 11.3.4.2.7. By Application
        • 11.3.4.2.8. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Cell Line Engineering
  • 13.2. Disposable Manufacturing Technology
  • 13.3. Perfusion Culture
  • 13.4. In-Silico Modelling
  • 13.5. Modular Factories

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Competition Outlook
  • 15.2. Company Profiles
  • 15.3. Company Details
  • 15.4. Financials (As Reported)
  • 15.5. Supply/ Value Chain Analysis
  • 15.6. SWOT Analysis
  • 15.7. Key Market Focus and Geographical Presence
  • 15.8. Planned Investments
  • 15.9. Market Positioning
  • 15.10. Import Export Analysis (By Region)
  • 15.11. Pricing Analysis (By Country)
  • 15.12. Leading Players Profiled
    • 15.12.1. Abbott Laboratories
    • 15.12.2. Abzena Ltd.
    • 15.12.3. AGC Biologics GmbH
    • 15.12.4. Althea Inc.
    • 15.12.5. Amgen Inc.
    • 15.12.6. Asymchem Laboratories Inc.
    • 15.12.7. Baxter Biopharma Solutions LLC
    • 15.12.8. Biocon Ltd.
    • 15.12.9. Biogen Inc.
    • 15.12.10. Boehringer Ingelheim GmbH
    • 15.12.11. Celgene Corporation
    • 15.12.12. Danaher Corporation
    • 15.12.13. Fujifilm Diosynth Biotechnologies
    • 15.12.14. Gilead Sciences, Inc
    • 15.12.15. Lonza Group
    • 15.12.16. MicroProtein Technologies, Inc.
    • 15.12.17. Novo Nordisk
    • 15.12.18. Patheon N.V. (Thermo Fischer Scientific)
    • 15.12.19. Proteogenix Inc.
    • 15.12.20. Proteus Digital Health Inc.

16. Strategic Recommendations